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INTRODUCTION
Leukemia is a consequence of malignant 
transformation of a single hematopoietic progenitor 
cell. A sequence of molecular events disrupts the 
process of differentiation and limited proliferation that 
characterizes normal hematopoiesis and generates a 
leukemic clone capable of expanding by indefinite self-
renewal (1). Acute lymphoblastic leukemia (ALL) is the 
most common type of pediatric cancer, accounting for 
nearly 30% of all pediatric cancers and 80% of childhood 
leukemias (2).
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In view of the morbidity potential of oral complications in patients with leukemia, this study evaluated the clinical and microbiological 
alterations that occur in the oral mucosa of children with acute lymphoblastic leukemia (ALL) undergoing antineoplastic chemotherapy 
and prophylactic administration of 0.12% chlorhexidine gluconate. the sample consisted of 17 children aged 2 to 12 years that underwent 
clinical examination of the oral mucosa for the detection of oral lesions. In addition, biological material was collected from labial and 
buccal mucosa for microbiological analysis. oral mucositis was observed in only 5 (29.4%) patients. Microbiological analysis revealed a 
reduced number of potentially pathogenic microorganisms, such as coagulase-negative staphylococci (47%), Candida albicans (35.3%), 
Klebsiella pneumoniae (5.9%), enteropathogenic Escherichia coli (5.9%), and Stenotrophomonas maltophilia (5.9%). Patients with 
oral mucositis showed a higher frequency of coagulase-negative staphylococci (80%) when compared with patients with  normal oral 
mucosa (33.3%). In conclusion, the results of the present study suggest that the prophylactic use of 0.12% chlorhexidine gluconate 
reduces the frequency of oral mucositis and oral pathogens in children with ALL. In addition, the present findings suggest a possible 
relationship between coagulase-negative staphylococci and the development of oral mucositis.
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oral mucositis is the most frequent complication 
of hematological cancer treatment, representing 
the main cause of pain (3-5) and a site favorable to 
the colonization and proliferation of bacteria (5,6). 
Studies have demonstrated an increase in the number 
and proportion of Gram-negative bacilli such as 
Escherichia coli, Pseudomonas aeruginosa, Klebsiella 
and Enterobacter spp. in the oral cavity of oncological 
patients, which are detected in approximately two-
thirds of all bacterial isolates (7,8). Gram-positive 
bacteria including coagulase-negative staphylococci 
and Enterococcus have also been identified in samples 
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collected from immunocompromised patients (9,10). 
Moreover, immunocompromised patients frequently 
develop candidiasis whose pathogenesis is determined 
by factors such as immunological state of the host, 
alterations in the oral microbiota caused by antineoplastic 
chemotherapy, and resistance to Candida (11,12).
Chlorhexidine gluconate is a drug widely used 
in dentistry, which acts on the damaged mucosa by 
forming a protective barrier consisting of a whitish 
membrane that results from the coagulation of serum 
and salivary proteins, thus reducing the severity of 
oral ulcerations (13). In addition, chlorhexidine has 
recognized fungicidal and bactericidal properties (14), 
and it has been shown that preventive treatment with 
this drug and oral hygiene care reduce the occurrence 
of oral complications related to hematological cancer 
treatment (14).
In light of these findings and in view of the 
scarcity of data regarding the microbiota associated with 
the occurrence of oral mucositis in the pediatric cancer 
population, the aim of this study was to clinically evaluate 
oral mucosal alterations and to qualitatively analyze 
the oral microbiota in children with ALL undergoing 
antineoplastic chemotherapy and prophylactic treatment 
with 0.12% chlorhexidine gluconate.
MATERIAL AND METHODS
Sample Characterization and Clinical Evaluation
the sample consisted of 17 children with ALL 
aged 2 to 12 years, with no preference for sex or race, seen 
at the Infant oncology and Hematology Center (CoHI) 
of the Varela Santiago Children’s Hospital, Natal, rN, 
Brazil. the study was approved by the ethics Committee 
of the Federal University of rio Grande do Norte, Brazil. 
the parents or responsible persons received information 
about the character and objectives of the investigation 
and signed a free informed consent form.
Mouthrinsing with 0.12% chlorhexidine 
gluconate was prescribed to the patients for 1 min twice 
a day, 30 min after breakfast and after the last meal at 
night. the 0.12% chlorhexidine gluconate solution 
was administered for 10 days throughout the phases of 
chemotherapy.
Clinical examination of the oral mucosa was 
performed daily during the period of hospitalization of 
the patient for chemotherapy to evaluate the presence 
of oral mucositis.
Microbiological Evaluation
Material for microbiological analysis was 
collected from the labial and buccal mucosa during 
the intensification phase after the end of prophylactic 
treatment with 0.12% chlorhexidine gluconate. First, a 
sterile swab was passed to remove saliva and shaded 
cells. Next, a second swab was vigorously passed to 
collect material adhered to the mucosa. After collection, 
the swab was placed in 1.0 mL reducing saline solution 
(0.85% NaCl + 0.1% sodium thioglycollate).
the collected material was homogenized 
for approximately 30 s in a Vortex Mixer (Labnet 
International, edison, NJ, USA) and then seeded onto the 
following culture media: mannitol salt agar, MacConkey 
agar, cetrimide agar, and Sabouraud agar (Difco Becton 
Dickinson, Franklin Lakes, NJ, USA). All plates were 
incubated under aerobic conditions for 24 to 48 h.
After incubation, the plates were examined 
regarding the presence of characteristic colonies of 
mannitol-fermenting and non-fermenting Staphylococcus 
(mannitol salt agar), fermenting and non-fermenting 
Gram-negative bacilli (MacConkey agar), P. aeruginosa 
(cetrimide agar), and yeast-like fungi (Sabouraud 
agar). Characteristic colonies of each microorganism 
were replated onto brain heart infusion (Difco Becton 
Dickinson) and incubated under the same conditions as 
used for isolation.
After incubation, the morphology and staining 
characteristics of the samples were determined by the 
Gram method modified by Kopeloff-Beerman and purity 
was confirmed by replating the samples onto the culture 
media used for primary isolation. None of the samples 
presented growth on cetrimide agar.
Staphylococci were characterized by traditional 
testing for free coagulase. All samples were coagulase 
negative and were stored for subsequent identification. 
Fermenting Gram-negative bacilli isolated on 
MacConkey agar were screened on triple sugar iron 
medium (Difco Becton Dickinson) and identified as E. 
coli and K. pneumoniae by the Mini-API identification 
system (bioMérieux, Craponne, France). E. coli was 
serotyped as classical enteropathogenic polyvalent B 
E. coli, serotypes o114, o125, o142 and o158, using 
polyvalent A-B-C serum (Probac do Brasil, São Paulo, 
SP, Brazil). the oxidative metabolism of non-fermenting 
Gram-negative bacilli was confirmed by the oxidation-
fermentation test in Hugh and Leifson medium and 
the samples were characterized as Stenotrophomonas 
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maltophilia by the Mini-API system (bioMérieux). 
Yeast-like fungi were identified as Candida albicans by 
staining of the colonies on CHroMagar (Difco Becton 
Dickinson) and their identification was confirmed by 
the production of chlamydospores.
RESULTS
In the present study, only 5 (29.4%) of the 17 
patients using 0.12% chlorhexidine gluconate developed 
oral mucositis of low severity, with a relatively similar 
distribution of cases according to the treatment phase 
(table 1). regarding anatomic location, oral mucositis 
affected the buccal mucosa in 2 cases, the gingiva in 
2 cases, and the tongue in 1 case. None of the patients 
presented disseminated mucositis.
the microbiological analysis revealed a very low 
frequency of potentially pathogenic microorganisms in 
the oral mucosa of the patients. Among Gram-positive 
bacteria, coagulase-negative staphylococci were the 
most frequently isolated and were present in samples 
collected from 8 (47.0%) patients, followed by C. 
albicans identified in samples from 6 (35.3%) patients. 
Among the Gram-negative bacteria, enteropathogenic 
E. coli, K. pneumoniae and S. maltophilia were isolated 
in 1 (5.9%) patient each.
Analysis of the presence of potentially pathogenic 
microorganisms according to the presence or 
absence of oral mucositis disclosed a low frequency 
of enteropathogenic E. coli, K. pneumonia, and S. 
maltophilia in both groups (table 2). Similarly, patients 
with normal oral mucosa and patients presenting oral 
mucositis exhibited similar frequencies of isolation of 
C. albicans (table 2). regarding coagulase-negative 
staphylococci, patients showing oral mucositis revealed 
a higher frequency of these Gram-positive bacteria 
when compared with patients with normal oral mucosa 
(table 2).
DISCUSSION
ALL is the most common childhood cancer in 
developed countries, accounting for one-third of all 
malignancies in this age group (1). oral mucositis is the 
major complication in children with ALL, a consequence 
of cytotoxic chemotherapy, which leads to a high 
morbidity including pain, oral dysfunction, dysphagia, 
bleeding, systemic weakness and infection (3,4,15,16).
the development of oral mucositis may result 
from both direct and indirect effects of chemotherapy on 
cells (17). the direct effect is determined by interference 
of drugs in cell production, maturation and replacement, 
whereas the indirect effect is related to myelosuppressive 
action of drugs, which deregulates the immune system 
and repair process, increasing the risk of infection 
associated with oral mucositis (18).
In the present study, oral mucositis was observed 
table 2. Distribution of patients according to the presence or 
absence of selected oral microorganisms and the presence or 




n % n %
Coagulase-negative 
staphylococci
Present 4 80.0 4 33.3
Absent 1 20.0 8 66.7
total 5 100.0 12 100.0
Klebsiella 
pneumoniae
Present 1 20.0 0 0.0
Absent 4 80.0 12 100.0
total 5 100.0 12 100.0
Escherichia coli
Present 0 0.0 1 8.3
Absent 5 100.0 11 91.7
total 5 100.0 12 100.0
Stenotrophomonas 
maltophilia
Present 0 0.0 1 8.3
Absent 5 100.0 11 91.7
total 5 100.0 12 100.0
Candida albicans
Present 2 40.0 4 33.3
Absent 3 60.0 8 66.7
total 5 100.0 12 100.0
table 1. Distribution of patients according to the presence or 
absence of oral mucositis and treatment phase.
Present Absent
n % n %
Induction 1 20.0 2 16.7
Consolidation 1 20.0 0 0.0
Intensification 2 40.0 8 66.6
Maintenance 1 20.0 2 16.7
total 5 100.0 12 100.0
Braz Dent J 22(4) 2011
Oral microbiota in children with ALL 315
in only 5 (29.4%) patients and affected different sites, 
including the buccal mucosa, gingiva, and tongue. A 
noteworthy fact is that none of the patients evaluated 
in this study showed disseminated mucositis. these 
findings corroborate the relationship between 
prophylactic administration of 0.12% chlorhexidine 
gluconate and reduced frequency and severity of oral 
mucositis. Accordingly, Pinto et al. (14) observed 
that systematic preventive treatment with 0.12% 
chlorhexidine gluconate and oral hygiene care reduce 
the occurrence of oral complications in children with 
ALL undergoing antineoplastic chemotherapy.
the oral cavity is one of the most complex 
environments in the body, containing a wide microbiota 
with distinct subsets predominating at different habitats, 
many of them potentially pathogenic (6). In the present 
study, coagulase-negative staphylococci were the 
most frequent microorganism isolated from the oral 
mucosa of children with ALL. In addition, patients 
showing oral mucositis revealed a higher frequency of 
coagulase-negative staphylococci when compared with 
patients with normal oral mucosa, suggesting a possible 
relationship between these microorganisms and the 
development of mucositis.
Staphylococci represent a group of Gram-
positive cocci. Most of these microorganisms are not 
pathogenic and reside mainly in the skin and mucous 
membranes of humans (19). However, there is a growing 
body of evidence to suggest that staphylococci can be 
frequently isolated from the oral environment of some 
specific groups such as children, the elderly and some 
groups with other systemic diseases such as those with 
rheumatoid arthritis and hematologic malignancies (20). 
In a systematic review conducted by Napeñas et al. (21), 
Staphylococcus was isolated from the oral microbiota of 
chemotherapy patients in 8 of the 13 analyzed studies. 
Despite of these findings, Smith et al. (20) further state 
that the role of Staphylococcus in the etiology of oral 
mucositis is controversial due to the diversity of the 
oral microbiota and the presence of this amphibiontic 
microorganism in the oral cavity of healthy patients.
Involvement of fungi in the development of 
oral mucositis has been subject of speculation and 
remains marginally controversial. Candidiasis is a 
common finding among patients receiving head and 
neck radiation or myeloablative chemotherapy. thus, 
it is not unexpected to isolate Candida from patients 
with mucositis, probably as a coincident condition, 
rather than causal (6). In the present study, C. albicans 
was isolated from samples of only 6 (35.3%) patients 
and no relationship could be established between the 
presence of this microorganism and the development of 
oral mucositis. Similarly, epstein et al. (12) studied 115 
patients undergoing hematopoietic cell transplantation 
and observed a lower frequency of C. albicans in the 
oral mucosa of patients using chlorhexidine as topical 
antifungal agent. In addition, the authors observed no 
correlation between Candida colonization and presence 
or severity of mucositis.
the oral bacterial infections can be due to 
opportunistic enterobacteria, such as Pseudomonas 
and E. coli (22). In immunocompromised patients, 
both the amphibiontic and the opportunistic microbiota 
can become pathogenically harmful and cause severe 
infections that may reach the bloodstream and lead to the 
occurrence of generalized infections (21). In the present 
study, it was observed a low frequency of Gram-negative 
bacteria in collected material, with enteropathogenic E. 
coli and K. pneumoniae being isolated from samples 
of 1 (5.9%) patient each. Similar results were found by 
Sheehy et al. (10) in a study about the oral microbiota 
of children undergoing liver transplantation, with 
Enterobacteria being isolated only rarely. Coherently, 
according to Napeñas et al. (21), most of the oral 
bacterial changes noted in pediatric patients undergoing 
chemotherapeutic regimens involve Gram-positive 
streptococci and staphylococci, whereas in adult patients, 
most changes involve Gram-negative organisms such as 
Enterobacteriaceae and Pseudomonas sp.
S. maltophilia is an opportunistic pathogen highly 
resistant to antibiotics which has gained importance 
over the last years in bacterial isolates obtained 
from clinical material. this microorganism has been 
associated to the development of bacteremia in patients 
with hematologic malignancies and neutropenia (23). 
In our study, one sample (5.9%) was positive for S. 
maltophilia. Labarca et al. (23) studied S. maltophilia 
infection in patients undergoing allogenic bone marrow 
transplant and observed that severe neutropenia and 
severe mucositis may favor infection by this bacterium 
through impairment of host defenses.
In conclusion, the results of the present study 
revealed a very low frequency of potentially pathogenic 
microorganisms in the oral mucosa of the children with 
ALL, a fact that can be explained by the prophylactic use 
of chlorhexidine in combination with daily oral hygiene 
care. Patients showing alterations in the oral mucosa 
exhibited a higher frequency of coagulase-negative 
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staphylococci when compared with patients with 
normal oral mucosa suggesting a possible relationship 
between these microorganisms and the development of 
oral mucositis.
RESUMO
tendo em vista o potencial de morbidade das complicações orais 
em pacientes com leucemia, este estudo avaliou as alterações 
clínicas e microbiológicas que ocorrem na mucosa bucal de 
crianças com leucemia linfoblástica aguda (LLA), submetidas 
à quimioterapia antineoplásica e administração profilática do 
gluconato de clorexidina 0,12%. A amostra foi constituída de 17 
crianças de 2 a 12 anos, as quais foram submetidas a exame clínico 
da mucosa oral para a detecção de lesões bucais. Além disso, 
foi coletado material biológico das mucosas labial e jugal para 
análises microbiológicas. A mucosite oral foi observada em apenas 
5 (29,4%) pacientes. A análise microbiológica revelou a presença 
de um número reduzido de microorganismos potencialmente 
patogênicos, como estafilococos coagulase-negativos (47%), 
Candida albicans (35,3%), Klebsiella pneumoniae (5,9%), 
Escherichia coli enteropatogênica (5,9%) e Stenotrophomonas 
maltophilia (5,9%). Pacientes com mucosite oral apresentaram 
uma maior freqüência de estafilococos coagulase-negativos 
(80%) quando comparados aos pacientes que exibiam mucosa 
oral normal (33,3%). em conclusão, os resultados do presente 
estudo sugerem que o uso profilático do gluconato de clorexidina 
0,12% reduz a freqüência de mucosite oral e de patógenos orais 
em crianças com LLA. Além disso, os presentes achados sugerem 
uma possível relação entre estafilococos coagulase-negativos e 
o desenvolvimento de mucosite oral.
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